Finanzen von TRex Bio, Inc. Common stock (TRXB)TRXBTRex Bio, Inc. Common stock

In the context of the broader market, TRXB competes directly with industry leaders such as RZLT and AVTX. With a market capitalization of $396.04M, it holds a significant position in the sector. When comparing efficiency, TRXB's gross margin of N/A stands against RZLT's N/A and AVTX's N/A. Such benchmarking helps identify whether TRex Bio, Inc. is trading at a premium or discount relative to its financial performance.

The financial metrics show a P/E ratio of 0 and a forward P/E of 0, suggesting no earnings expectations. The EV to EBITDA is negative at -8.61, indicating potential issues with profitability.